The Aveir pacemaker offers patients a less invasive and more efficient solution for managing cardiac arrhythmias.
While traditional pacemakers are implanted with leads, Aveir eliminates the need for wires and makes the procedure minimally invasive.
As of mid-December, Dr. Georgeson has successfully performed two procedures using the new technology.
The Aveir pacemaker also has longer battery life than traditional pacemakers, with batteries expected to last 15 to 20 years versus the traditional eight to 12. It is also smaller than a AAA battery, offering more comfort for patients.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.